Study suggests Pfizer/BioNTech vaccine effective against Covid-19 variants
New research suggests that Pfizer/BioNTech’s mRNA Covid-19 vaccine, BNT162b2, protects against two variants of SARS-CoV-2,...
New research suggests that Pfizer/BioNTech’s mRNA Covid-19 vaccine, BNT162b2, protects against two variants of SARS-CoV-2,...
The UK’s healthcare regulator the Medicines and Healthcare products Regulatory Agency (MHRA) has approved Moderna’s mRNA...
Immunotherapy company ImmunityBio has partnered with Microsoft to leverage the latter’s Azure platform to create...
Artificial intelligence (AI) drug discovery company Exscientia has expanded its ongoing anti-viral drugs partnership with...
Next generation biologics company Noveome Biotherapeutics will evaluate its lead programme ST266 as a potential...
Johnson & Johnson (J&J) has expanded its partnership with the US Department for Health and...
Non-profit the Coalition for Epidemic Preparedness Innovations (CEPI) has received £210m from the UK Government...
US-based Novavax has published top-line Phase III data for its seasonal influenza vaccine Nanoflu in...